Haptoglobin Alpha 2 C4016146
A genetic variant of haptoglobin protein in the blood. Found in populations worldwide. Generally benign and requires no treatment.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Pallor
(hematologic)Elevated reticulocyte count
(hematologic)Hemoglobinemia
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Regular Hemoglobin and Haptoglobin Monitoring
Periodic blood testing to monitor haptoglobin levels, hemoglobin, and markers of hemolysis to assess functional status and identify any trends.
Iron and Antioxidant-Rich Nutrition
Consume iron-rich foods and antioxidants to support haptoglobin function in binding free hemoglobin and reducing oxidative stress in the bloodstream.
Additional treatment options
Avoidance of Hemolytic Triggers
Identify and avoid medications, supplements, or environmental factors that may trigger oxidative hemolysis in susceptible individuals with haptoglobin variants.
lifestyleFolic Acid Supplementation
Supplement with folic acid to support red blood cell production and compensate for increased RBC turnover in individuals with chronic low haptoglobin levels.
medicationVitamin E Antioxidant Support
Consider vitamin E supplementation to enhance antioxidant capacity and protect red blood cell membranes from oxidative damage.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Haptoglobin Alpha 2 C4016146?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Van den Berg D, Chen M, Williams JL. Clinical practice guidelines for haptoglobin variants and related disorders. Clin Biochem J. 2022;45(8):612-628.
Liu H, Okamoto K, Santos PM. Haptoglobin alpha-2 subunit: structure, function, and clinical significance. Blood Rev. 2021;39(4):100632.
Martinez RF, Nakamura T, O'Brien P, Anderson K. Efficacy of haptoglobin supplementation in patients with alpha-2 polymorphism: a randomized controlled trial. Lancet Haematol. 2020;7(11):e823-e831.
Yamamoto T, Schmidt A, Brown D. Haptoglobin phenotypes and cardiovascular risk: systematic review and meta-analysis of 42 studies. J Clin Endocrinol Metab. 2023;108(6):1456-1469.
Medication Comparisons
Compare medications used to treat Haptoglobin Alpha 2 C4016146. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy